A research domain is the area of the UK in which nine research sites are located and the research is conducted. It is not relevant where the research participants are resident, or which Primary Care Trust is responsible for the participants' primary care. This includes domains where participant-related research procedures specified in the protocol - including recruitment and informed consent - are carried out. Referral of a patient (possibly from another domain) for assessment and possible recruitment is not part of the conduct of the trial. The following are not considered to be research sites:
A "domain" is defined as follows:
Where the Chief Investigator plans eventually to conduct a study at sites in two or more domains, it should be allocated by Central Allocation System for review as a multi-domain study, even where research sites have so far been identified in one domain only. In rare cases, a study may be taking place at a single research site spanning the boundaries of two domains.
If the study is a Clinical Trial of an Investigational Medicinal Product (CTIMP), it should be allocated by Central Allocation System.
Yes. The NRES website contains further guidance of what a patient information sheet should include.
Help is also available from the Research Design Service on 0117 342 0233.
Yes, however the NHS Research Ethics Committee undertaking the ethical review will need to approve the generic wording of any advertisements as well as the type of places they will be placed (eg local press/national press/GP surgeries). Locality assessors will need to sign off any locality issues, such as where the adverts will be placed specifically and any contacts given on the advert.